You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR CASIMERSEN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for casimersen

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02500381 ↗	Study of SRP-4045 and SRP-4053 in Participants With Duchenne Muscular Dystrophy (DMD)	Recruiting	Sarepta Therapeutics	Phase 3	2016-09-28	The main objective of this study is to evaluate the efficacy of SRP-4045 and SRP-4053 compared to placebo in participants with DMD with out-of-frame deletion mutations amenable to skipping exon 45 and exon 53, respectively.
NCT02500381 ↗	Study of SRP-4045 and SRP-4053 in Participants With Duchenne Muscular Dystrophy (DMD)	Recruiting	Sarepta Therapeutics, Inc.	Phase 3	2016-09-28	The main objective of this study is to evaluate the efficacy of SRP-4045 and SRP-4053 compared to placebo in participants with DMD with out-of-frame deletion mutations amenable to skipping exon 45 and exon 53, respectively.
NCT03532542 ↗	An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy	Enrolling by invitation	Sarepta Therapeutics	Phase 3	2018-08-02	The main objective of this study is to evaluate the safety and tolerability of long-term treatment with casimersen or golodirsen in patients with Duchenne muscular dystrophy (DMD).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for casimersen

Condition Name

Chart
Table

Condition Name for casimersen
Intervention	Trials
Duchenne Muscular Dystrophy	3
DMD	1
Muscular Dystrophy	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for casimersen
Intervention	Trials
Muscular Dystrophy, Duchenne	3
Muscular Dystrophies	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for casimersen

Trials by Country

Map
Table

Trials by Country for casimersen
Location	Trials
United States	42
Germany	3
Poland	3
Spain	3
Belgium	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for casimersen
Location	Trials
Ohio	3
California	2
Arizona	2
Wisconsin	2
Virginia	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for casimersen

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for casimersen
Clinical Trial Phase	Trials
Phase 3	2
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for casimersen
Clinical Trial Phase	Trials
Active, not recruiting	1
Enrolling by invitation	1
Recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for casimersen

Sponsor Name

Chart
Table

Sponsor Name for casimersen
Sponsor	Trials
Sarepta Therapeutics, Inc.	3
Sarepta Therapeutics	2
Kevin Flanigan	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for casimersen
Sponsor	Trials
Industry	5
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.